Skip to content

Research for combined therapy of traditional Chinese medicine and application in children with macrolide-resistant Mycoplasma pneumoniae pneumonia

Research for combined therapy of traditional Chinese medicine and application in children with macrolide-resistant Mycoplasma pneumoniae pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000002992
Enrollment
Unknown
Registered
2020-02-09
Start date
2020-02-14
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mycoplasma pneumoniae pneumonia

Interventions

Sponsors

Shanghai Children's Medical Center affiliated to school of medicine, Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 8 Years

Inclusion criteria

Inclusion criteria: 1. Male or female children aged 3 to 8 years old; 2. Imaging examination suggests pneumonia; 3. Positive result of etiological examination of Mycoplasma pneumoniae; 4. Gene mutation at position 2063 or 2064; 5. The parents of the subjects will be signed informed consent, and to be able to cooperate.

Exclusion criteria

Exclusion criteria: 1. Children are associated with other serious respiratory diseases such as congenital tracheoesophageal fistula, congenital malformation, airway compression of laryngotracheal bronchomalacia and (or) stenosis, bronchial cyst, mediastinal tumor, ciliary dyskinesia; 2. Children are with severe liver and kidney diseases, cardiovascular diseases, endocrine diseases, blood system diseases, nervous system diseases; 3. Children are to test drug allergy; 4. According to the doctor's judgment, Children are easy to cause the loss of visitors.

Design outcomes

Primary

MeasureTime frame
TCM syndrome score;

Contacts

Public ContactZhang Hao
zhang123hao2004@163.com+86 18930830639

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026